Vasculitis Market: Industry Size, Growth, Trends & Forecast 2018-2023 Vasculitis Market PDF | Page 2

Global vasculitis market size, share, market trends, research and analysis
report by diagnosis (blood test, urine test, imaging test, angiography, biopsy)
by therapeutic (corticosteroids, immunosuppressants, biologics) forecast
2018-2023
Orion Market Research (OMR), recently published a market research report on the global vasculitis
market. According to the OMR analysis, the global vasculitis market is expected to grow at a significant
rate during 2018-2023. The global vasculitis market has witnessed a significant growth due to increasing
healthcare expenditure and growing R&D in vasculitis treatment. The global vasculitis market is
segmented on the basis of type, diagnosis tests, therapeutic class, end user and geography. The report
provides detailed and insightful chapters on market overview, key findings, strategic recommendations,
competitive landscape, market determinants, key company analysis, company profiling, market
segmentation, geographical analysis and analyst insights .
Full report of global vasculitis market is available at : https://www.omrglobal.com/industry-
reports/vasculitis-market/
“increasing pipeline products holds a huge opportunity for the growth of global vasculitis market in the
future. The product portfolio of the market players is flooded with new and innovative products. The
market players are receiving approval by the government authorities such as FDA to continue their
development and start their next phase of the product. For example: InflaRx N.V. received the US FDA
approval in January 2018 for its Investigational New Drug (IND) application. This will allow the company
to begin its planned phase II study for determining the efficacy and safety of IFX-1, a first-in-class anti-
human complement factor C5a antibody, in patients living with ANCA-associated vasculitis (AAV).
The market on the basis of geography is divided among four major regions – North America, APAC,
Europe, and Rest of the world. North America is the leading market. North American market is driven by
rising healthcare expenditure and growing R&D in vasculitis treatment. In addition, cohesive
reimbursement policies, as well as presence of key players in the region further augments the growth of
global vasculitis market in North America. Asia Pacific market is expected to have the highest CAGR
amongst all region during the forecast period (2018-2023). APAC market is driven by the increasing
prevalence of microscopic polyangiitis (MPA) in the APAC region, especially in China and Japan.